Quantum BioPharma is trading 6.2% up at $3.07 as investors respond to encouraging preliminary data from its multiple sclerosis imaging study with Massachusetts General Hospital and a broader risk-on move in U.S. equities.
- The stock is extending its late-July rebound, with major indices trading sharply higher as geopolitical tensions ease.
- Positive economic data is supporting a renewed appetite for growth and small-cap names, contributing to the upward momentum.